India Adds Remdesivir to COVID-19 Treatment Protocol, an Industrial Info Market Brief
India Adds Remdesivir to COVID-19 Treatment Protocol, an Industrial Info Market Brief
Attachment: India COVID 0620
India's Ministry of Health and Family Welfare has included anti-viral drug remdesivir in its updated Clinical Management Protocol for COVID-19 patients. In a press release, the Health Ministry said that the updated protocol included remdesivir as an "investigational therapy" only for restricted emergency use.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
